Scientific Abstracts 2023
DOI: 10.1136/annrheumdis-2023-eular.147
|View full text |Cite
|
Sign up to set email alerts
|

Pos0838 agomelatine Identified From the Fda-Approved Drug Library Is Therapeutic Against Collagen Induced Arthritis

Abstract: BackgroundTreatment effect of tumor necrosis factor α (TNFα) inhibitors is still low in patients with rheumatoid arthritis (RA), around 50%-70%. Thus more drugs by targeting proliferation of synovial fibroblasts (FLS) and TNFα induced inflammatory cytokine production are needed. Repurposed use of drugs that have been used in clinic is a quick and cost-effective way to find new drugs.ObjectivesThis study aims to screen drugs that could inhibit the proliferation and inflammation induced by TNFα in FLS from FDA a… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles